Marimed (MRMD) FCF Payout Ratio Growth (1y) (2018 - 2026)
Marimed (MRMD) FCF Payout Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -14.68% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -49.97% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -49.30% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Marimed | 33.57 Mn | 25.13 Mn | 16.23 Mn | 250.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 250.12% |
| Mar 31, 2026 | -6.71% |
| Dec 31, 2025 | 187.03% |
| Sep 30, 2025 | 109.26% |
| Jun 30, 2025 | -193.75% |
| Mar 31, 2025 | 119.83% |
| Dec 31, 2024 | 7.56% |
| Sep 30, 2024 | -346.26% |
| Jun 30, 2024 | 100.44% |
| Mar 31, 2024 | -3,652.79% |
| Dec 31, 2023 | -101.37% |
| Sep 30, 2023 | -55.29% |
| Jun 30, 2023 | -3,370.53% |
| Mar 31, 2023 | -133.63% |
| Dec 31, 2022 | 3,381.77% |
| Sep 30, 2022 | 38.25% |
| Jun 30, 2022 | -204.36% |
| Mar 31, 2022 | 83.33% |
| Dec 31, 2021 | 107.83% |
| Sep 30, 2021 | 125.82% |